BSE filing, NSE: SAMPRE. Summary written from the filing by ALFA Finder's alert engine.
Sampre Nutritions Ltd: key numbers
- Share price
- ₹4.24
- Market cap
- ₹37.80 Cr
- Revenue (annual)
- ₹43.35 Cr
- Net profit (annual)
- ₹3.08 Cr
- P/E (TTM)
- 11.5×Sector 38.3×
- Promoter holding
- 14.04%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Sampre Nutritions Ltd
All →Sampre Nutritions Capital Structure Change
Sampre Nutritions allotted 1,770,710 equity shares at ₹42 each to promoters upon unsecured loan conversion. This capital issuance totals ₹7.44 Crore.
- Value
- ₹7.44 Cr
Sampre Nutritions Annual General Meeting
Sampre Nutritions Limited conducted its 35th Annual General Meeting on September 4, 2026. Shareholders considered the adoption of financial statements and a revision in director remuneration.
Sampre Nutritions Capital Structure Change
Sampre Nutritions received BSE in-principal approval for a preferential issue of 17.71 lakh equity shares. The issue involves converting ₹7.44 Crore of unsecured loans into equity.
- Value
- ₹7.44 Cr
Sampre Nutritions Other Announcement
Sampre Nutritions Ltd has filed its quarterly shareholding pattern for the period ended December 31, 2025, as mandated by SEBI Regulation 31.
Sampre Nutritions Annual Report
Sampre Nutritions has filed its Annual Report for the financial year 2025-26, including the notice for its 35th Annual General Meeting.
Sampre Nutritions Annual General Meeting
Sampre Nutritions Limited will hold its 35th Annual General Meeting on 04 September 2026 via video conferencing to transact ordinary and special business.
Other other announcement announcements
All →Mahindra & Mahindra Financial Services Other Announcement
Mahindra & Mahindra Financial filed its ALM statement as of September 30, 2026, submitted to RBI. It is a periodic regulatory return with no new transaction.
ACME Solar Holdings Other Announcement
ACME Solar filed the CARE Ratings monitoring agency report on its Rs.2,800 crore QIP for the quarter ended 30 September 2026. The report shows no deviation from the offer objects.
eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.